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Abstract
Background. This study investigated whether the single-use rhinolaryngoscope is clinically
and economically comparable to the conventional reusable rhinolaryngoscope within a
tertiary otolaryngology centre in the UK.
Methods. A non-blinded, prospective and single-arm evaluation was carried out over a 5-day
period, in which micro-costing was used to compare single-use rhinolaryngoscopes with
reusable rhinolaryngoscopes.
Results. Overall, 68 per cent of the investigators perceived the single-use rhinolaryngoscope to
be ‘good’ or ‘very good’, while 85 per cent believed the single-use rhinolaryngoscope could
replace the reusable rhinolaryngoscope (n = 59). The incremental costs of reusable rhinolar-
yngoscope eyepieces and videoscopes in the out-patient clinic, when compared to single-
use rhinolaryngoscopes, were £30 and £11, respectively. The incremental costs of reusable
rhinolaryngoscope eyepieces and videoscopes in the acute surgical assessment unit, when
compared to single-use rhinolaryngoscopes, were −£4 and −£73, respectively.
Conclusion. The single-use rhinolaryngoscope provides a clinically comparable, and poten-
tially cost-minimising, alternative to the reusable rhinolaryngoscope for use in the acute
surgical assessment unit of our hospital.
Introduction
Endoscopy allows for the enhanced visualisation, inspection, manipulation and treatment
of internal organs or tissues, without the need for an incision.1 The endoscope has
revolutionised otolaryngology by virtue of its ability to directly visualise the nose, throat
and airway, in an emergency, in-patient or out-patient setting. There are a range of
indications for the use of an endoscope in otolaryngology, both in emergencies and
non-emergencies, including airway obstruction, foreign body removal, hoarseness, globus
sensation, recurrent epistaxis, cancer surveillance, evaluation of obstructive sleep apnoea,
fibre-endoscopic evaluation of swallowing, and assessment and treatment of vocal fold
lesions.2
In current practice, once an endoscope has been utilised on a single patient, it is
required to undergo reprocessing, as required by the Health and Social Care Act.3,4 If con-
taminated, flexible endoscopes pose a moderate degree of infection risk, and therefore
require ‘high-level disinfection’ to eliminate vegetative bacteria, mycobacteria, fungi and
viruses. The importance of this practice is underpinned by the emergence of multi-drug
resistance, and organisms such as mycobacteria, bacterial spores, Creutzfeldt–Jakob
disease (CJD) and variant CJD.5 Accordingly, the 2015 risk assumptions put forward
by the UK Advisory Committee for Dangerous Pathogens and Health Technical
Memorandum 01-01 recommend that if a patient with an undiagnosed neurological
illness undergoes an invasive endoscopy, where variant CJD cannot be excluded, or
where the sub-classification of CJD infection is still pending, then it is necessary to
place the device into temporary quarantine.5,6 Unless the potential variant CJD contam-
ination can be subsequently rescinded, then the quarantined endoscope cannot be
returned to normal use on other patients.5,6
ENT UK provides national guidelines for endoscope decontamination.7
Decontamination can take the form of chemical decontamination (e.g. wipe systems
such as chlorine dioxide) or central decontamination systems. Chemical decontamination
is less expensive but is deemed an inferior method of decontamination.7 Central decon-
tamination has a higher cost, and ENT UK guidelines state that hospitals considering
central decontamination models should be aware of the significant cost implications of
such models. While the risk of cross-infection and harm remains low, the consequence
of prion transmission remains a serious potential risk. ENT UK concurs with the advice
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previously described by the UK Advisory Committee for
Dangerous Pathogens and Health Technical Memorandum
01-06 regarding variant CJD risk and endoscope decontamin-
ation.7 Every hospital or clinic should maintain a robust sys-
tem of individual endoscope traceability, with regular audit.
In particular, it states that hospitals should consider disposable
flexible endoscopes available for use in patients with variant
CJD.7
At the time of submission, the coronavirus disease 2019
(Covid-19) pandemic has provided further emphasis on the
importance of thorough infection control during endoscopic
examination, which is deemed to be an aerosol generating pro-
cedure. ENT practitioners themselves are deemed to be at high
risk of Covid-19 transmission. ENT UK have provided clear
guidance that endoscopy be carried out by video monitoring
on all patients (regardless of Covid-19 status) where possible,
rather than direct viewing through an eyepiece.8 Clear guid-
ance is also provided for the decontamination of reusable
scopes if used, which involves full donning of personal pro-
tective equipment and a specific decontamination procedure.8
Inadequate documentation of patients’ details and their
relative risk of infection can therefore lead to the disposal of
unnecessary reusable endoscopes and a consequential increase
in capital expenses.9,10 Even if adequately documented, repro-
cessing can cost between £41 and £124 per procedure; more-
over, the homogeneity and quality of the reprocessing
practice to ensure ‘high-level disinfection’ cannot always be
guaranteed.11
Rhinolaryngoscopes are currently available as rigid scopes,
eyepiece scopes and videoscopes. Although rigid rhinolaryn-
goscopes are primarily used in operating theatres, eyepiece
scopes and videoscopes are commonly used for procedures
in both out-patient and in-patient consultations. The eyepiece
scope allows visualisation through an eyepiece at the end of the
device, allowing only the user to visualise the resultant image.
In contrast, the videoscope allows the picture to be visualised
on a monitor stack. Once used, both of these items of equip-
ment should undergo the relevant decontamination process
prior to subsequent use, and therefore are deemed reusable
rhinolaryngoscopes.3
The Ambu® aScope™ 4 RhinoLaryngo (Figure 1) is a
single-use video endoscope that is available with and without
a working channel. The Ambu aScope 4 RhinoLaryngo Slim
(single-use rhinolaryngoscope), without a working channel,
is intended for routine examinations of the upper airway
anatomy (Figure 1).12 Immediately after patient use, the single-
use rhinolaryngoscope is disposed of into a clinical waste bin.
This practice prevents any transmission of infectious agents
between patients, and reduces the costs associated with
reprocessing.
Previous research with a single-use bronchoscope, the Ambu
aScope 4 Broncho, clearly demonstrated the positive organisa-
tional impact created by a single-use device, reducing the
number of support processes needed to ensure the provision
of a clean and ready-to-use bronchoscope.13 Furthermore, the
single-use bronchoscope has been proven to reduce the delay
between the indication for bronchoscopy and the initiation of
the actual procedure, while having a comparable environmental
impact compared to reusable bronchoscopes.14,15 Although
there is limited published evidence to support the use of single-
use rhinolaryngoscopes, it is likely that the benefits of single-use
bronchoscopes will also apply to single-use rhinolaryngoscopes
as the reprocessing procedure is similar.9,16 However, the
current lack of evidence prevents evidence-based decisions on
whether the implementation of single-use rhinolaryngoscopes
is clinically and economically practical.
We aimed to investigate whether the single-use rhinolaryn-
goscope is clinically comparable to the conventional reusable
rhinolaryngoscope, and to compare the cost of introducing
single-use technology as an alternative to the conventional
reusable rhinolaryngoscope across different clinical settings.
Materials and methods
A single-arm, non-blinded, prospective trial and cost-
comparison exercise was carried out at a tertiary otolaryngol-
ogy centre in the UK. The trial was conducted from 24th to
28th June 2019. A pre-trial training session was held, lasting
30–60 minutes, to describe the intentions of the study, and
to introduce investigators without previous experience to the
single-use rhinolaryngoscope technology and monitor (the
Ambu aView™).
At the training session, the investigators conducted proce-
dures on manikins under the supervision of an Ambu clinical
trainer. Throughout the trial duration, an Ambu representative
was available onsite for technical support. The investigators
were then asked to employ the single-use rhinolaryngoscope
for clinical procedures within the device’s intended purpose,
and then complete a pre-printed evaluation form. A Likert
scale was used to quantify a range of parameters and provide
an evaluation of the equipment, including image quality,
advancing, navigation, overall perception and ergonomics.
The investigators were also asked whether they had to change
from the single-use rhinolaryngoscope to a reusable rhinolar-
yngoscope during their clinical procedures.
The overall aim of the evaluation was to ascertain whether
the single-use rhinolaryngoscope could replace the reusable
rhinolaryngoscope, and whether the investigators had to
change from the single-use system to the reusable system
during each clinical procedure. The investigators answered
the questions using either ‘yes’ or ‘no’ responses. The Likert
scores were then transformed into a numerical score from 1
to 5. The results are shown as mean ± standard deviation
values. Ordinary least squares regression analysis was subse-
quently conducted to determine if the evaluation scores influ-
enced the investigators’ opinion as to whether the single-use
rhinolaryngoscope could replace the reusable rhinolaryngo-
scope. The evaluation form for the Ambu aScope 4
RhinoLaryngo Slim single-use rhinolaryngoscope is shown
Fig. 1. Image of the Ambu aScope 4 RhinoLaryngo Slim and Intervention scopes
along with the Ambu aView (monitor).
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in Figure 1 in the supplementary material, available on The
Journal of Laryngology & Otology website.
Two investigators independently reviewed the evaluation
forms for validity. As a result of this review, questionnaire
numbers 13 and 61 were excluded from the final analysis.
Questionnaire 13 was excluded because the scores provided
did not match the investigator’s written comments.
Questionnaire 61 was excluded because the investigator used
a different scope.
The cost-comparison analysis was based on a hospital set-
ting with a short time perspective. The main endpoint was the
incremental cost of the procedure when the single-use rhino-
laryngoscope was used, in comparison with the conventional
reusable eyepiece and video rhinolaryngoscope. The rigour
of the base-case result was assessed via two-way sensitivity
analysis, and a break-even point was calculated dependent
on the volume of procedures.
Micro-costing was conducted on reusable rhinolaryngo-
scopes between 24th and 27th September 2019.
Rhinolaryngoscopes were followed and tracked from the fina-
lised procedure, through reprocessing, and until the initiation
of a new procedure. All person-hours, single-use equipment,
utilities and capital equipment utilised during the supporting
processes were noted, and each was allocated a specific cost.
Personnel costs were based on the mean wage for pay band
2.17 Capital costs were projected via the consumer price index
to 2018 prices, and discounted at a rate of 3.5 per cent to
account for time preference.18,19 The amortisation period was
five years for capital equipment in the out-patient clinic, three
years in the acute surgical assessment unit, and eight years for
reprocessing capital equipment.18 Overhead costs were added
at a rate of 20 per cent to account for additional capital, repair
and reprocessing costs.20
The final dataset was then subdivided into five categories:
(1) objective evaluation of equipment; (2) a comparative evalu-
ation against the scope normally used on a day-to-day basis;
(3) overall evaluation; (4) qualitative comments; and (5) cost
analysis.
Results
The single-use rhinolaryngoscope was used on 200 occasions
by a total of 16 investigators (9 otolaryngology consultants, 6
otolaryngology registrars and 1 core surgical trainee).
The questionnaires were completed on 61 occasions, thus
yielding a compliance rate of 30.5 per cent; this represented
a mean of 3.7 ± 0.9 completed questionnaires per investigator.
Single-use rhinolaryngoscopes were used in four types of
documented procedures: nasendoscopy (53 procedures),
laryngoscopy (1 procedure), pharyngolaryngoscopy (1 proced-
ure) and nasal examination (1 procedure); in three cases, the
exact procedure was not documented.
The evaluation questions and mean scores are displayed in
Table 1. A mean of 3 per cent of participants changed from the
single-use rhinolaryngoscope to a reusable rhinolaryngoscope.
A mean of 85 per cent believed the single-use rhinolaryngo-
scope could replace the reusable rhinolaryngoscope. The
single-use rhinolaryngoscope was rated above 2.50 in all
domains (where 1 = ‘very poor’ or ‘much worse’, and 5
= ‘very good’ or ‘much better’).
Objective evaluation
The results for overall perception, navigational ability and
image quality can be seen in Figure 2. The single-use rhinolar-
yngoscope was deemed acceptable or better for overall percep-
tion, navigation and image quality by 96 per cent, 95 per cent
and 91 per cent of participants, respectively.
Single-use versus reusable rhinolaryngoscopes
The results comparing image quality, ergonomics, and advan-
cing and navigation are shown in Figure 3. The single-use rhi-
nolaryngoscope was deemed ‘better’ or ‘much better’ than the
reusable rhinolaryngoscope for image quality, ergonomics, and
advancing and navigation in 24 per cent, 13 per cent and 12
per cent, respectively. Participants found no difference
between the single-use rhinolaryngoscope and the reusable
rhinolaryngoscope for image quality, ergonomics, and advan-
cing and navigation in 32 per cent, 53 per cent and 47 per cent,
respectively.
Overall evaluation
Overall, 3 per cent of the investigators reported that they had
to change to the reusable rhinolaryngoscope because of patient
intolerance. Eighty-five per cent of investigators believed that
the single-use rhinolaryngoscope could successfully replace
the reusable rhinolaryngoscope.
Overall evaluation dependent on evaluation score
Overall, there was a significant association between the evalu-
ation scores and an investigators’ opinion as to whether the
single-use rhinolaryngoscope could replace the reusable rhino-
laryngoscope (F(6,52) = 5.02, p < 0.001). However, the only
Table 1. Evaluation questions and mean scores
Question Likert scores* (mean ± SD)
How would you rate image quality during the procedure just performed? 3.92 ± 0.98
How would you rate navigation of aScope4 RhinoLaryngo Slim through the relevant area? 3.98 ± 0.91
How would you rate overall perception of quality & functionality of aScope 4 RhinoLaryngo Slim for the procedure performed? 3.86 ± 0.85
How would you rate advancing & navigation compared to the scope you normally use? 2.81 ± 0.95
How would you rate ergonomics in the handle compared to the scope you normally use? 2.88 ± 0.90
How would you rate image quality compared to the scope you normally use? 3.12 ± 1.01
During the procedure, did you have to change from aScope 4 RhinoLaryngo Slim to your normal scope? Yes: 3 ± 18%
Do you consider that aScope 4 RhinoLaryngo Slim can replace your existing reusable scope for the procedure performed? Yes: 85 ± 36%
Likert scores were based on 1 (‘very poor’ or ‘much worse’) to 5 (‘very good’ or ‘much better’). *Unless indicated otherwise. SD = standard deviation
792 R Mistry, R V Russell, N Walker et al.
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0022215120001656
Downloaded from https://www.cambridge.org/core. IP address: 86.155.198.194, on 06 Nov 2020 at 14:27:32, subject to the Cambridge Core terms of use, available at
individual evaluation variable that had a significant effect on
the investigator’s decision that the single-use rhinolaryngo-
scope could replace the reusable rhinolaryngoscope was the
evaluation of navigation (t(52) = 2.95, p = 0.005).
Qualitative feedback
In total, there were 25 qualitative feedback comments. This
feedback was independently classified into three categories
by two of the authors as negative, neutral or positive. The
majority of the positive comments related to patient comfort,
while most of the negative comments related to image quality.
The neutral comments mostly related to the use of the scope in
a ‘standard’ patient (deemed not to have complex anatomy or
needs) (Figure 4).
Cost analysis
In both the out-patient clinic and acute surgical assessment
unit settings, the cost of a procedure performed using the
single-use rhinolaryngoscope was £105. The base-case results
were based on 4957 and 783 procedures per annum in the
out-patient clinic and acute surgical assessment unit, respect-
ively. The volume of procedures in the acute surgical assess-
ment unit was based on an assumption that one-third of all
otolaryngology patients undergo nasoendoscopy. The capital
and repair cost input for the out-patient clinic cost analysis
can be found in supplementary material Tables 1 and 2,
available on The Journal of Laryngology & Otology website.
The capital and repair cost input for the acute surgical
assessment unit can be found in supplementary material
Tables 3 and 4. Capital, consumable and utilities, and
personnel times, for reprocessing reusable
Fig. 2. Objective evaluations of the (a) overall perception, (b) navigation and (c)
image quality, of the single-use rhinolaryngoscope.
Fig. 3. Evaluations of (a) image quality, (b) ergonomics, and (c) advancing and navi-
gation of single-use rhinolaryngoscopes in comparison with reusable
rhinolaryngoscopes.
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rhinolaryngoscopes can be seen in supplementary material
Tables 5–7, respectively.
In the out-patient clinic, the cost of the eyepiece rhinolar-
yngoscope procedure was £75, including £10, £24 and £41,
for capital, repair and reprocessing, respectively. In contrast,
the cost of the video rhinolaryngoscope procedure in the out-
patient clinic was £94, including £30, £23 and £41, for capital,
repair and reprocessing, respectively. The incremental costs of
reusable rhinolaryngoscope eyepieces and videoscopes in the
out-patient clinic, when compared to single-use rhinolaryngo-
scopes, were £30 and £11, respectively. The break-even point
occurred at 102 and 151 procedures per eyepiece and video
rhinolaryngoscope, respectively (Figure 5).
In the acute surgical assessment unit, the cost of the eye-
piece scope procedure was £109, including £32, £39 and £38,
for capital, repair and reprocessing, respectively. The cost of
the videoscope procedure in the acute surgical assessment
unit was £178, including £101, £39 and £38, for capital, repair
and reprocessing, respectively. The incremental costs of
reusable rhinolaryngoscope eyepieces and videoscopes in the
acute surgical assessment unit, when compared to single-use
rhinolaryngoscopes, were −£4 and −£73, respectively. The
break-even point occurred at 104 and 215 procedures for the
eyepiece and video rhinolaryngoscope, respectively. Two-way
sensitivity analysis was carried out for both settings, and
showed that the base-case was sensitive to procedure volume,
reprocessing and capital costs (Figure 5).
In order to ensure the provision of a ready-to-use reusable
rhinolaryngoscope, 21 minutes of active personnel time was
required. Furthermore, in the out-patient clinic, one dedicated
member of staff was required, full-time, to ensure that reusable
scopes were always available.
In the acute surgical assessment unit, all of the purchased
reusable rhinolaryngoscopes were quarantined over a three-
year period because of unrecorded procedures, or patient
infection status; consequently, prion contamination could
not be excluded (please see Tables 1–7 in the supplementary
material, available on The Journal of Laryngology & Otology
website, for all cost analysis data).
Discussion
Overall, our analyses showed that the user experience and accept-
ability of the single-use rhinolaryngoscope was positive. This is in
accordance with a previous evaluation carried out in Germany.16
Furthermore, our qualitative data demonstrated that the single-
use rhinolaryngoscopewas considered to be ‘acceptable’ or ‘better’
inmore than 50 per cent of responses with regard to all three para-
meters (image quality, ergonomics, and advancing and naviga-
tion). Moreover, 85 per cent of participants believed that the
single-use rhinolaryngoscope could replace the reusable system.
In particular, qualitative comments from investigators revealed
that patient comfort was deemed to be a particular advantage; typ-
ical comments included ‘patient found it more comfortable’ and
‘better tolerated, excellent images’.
User acceptability: image quality
Non-comparative data relating to image quality were generally
positive (69 per cent ‘good’ or ‘very good’); however, 33 per
cent of the investigators rated the single-use rhinolaryngoscope
as ‘worse’ or ‘much worse’ than the reusable system. This was in
line with some of the qualitative feedback, which stated that ‘the
optics are not as accurate/sharp as the traditional scope but still
passable for the purpose required’. Another investigator stated
‘good enough for clinical out-patients or acute airway. Limited
use for laryngeal detail’. These comments highlight the import-
ance of the context in which the device is used.
Concerns were also raised regarding the monitor. For
example, one investigator stated that ‘the optics were balanced
by closing all the curtains, thus reducing reflection on the moni-
tor’. Consequently, there is a need for the system to be used in an
environment that allows good visualisation of the images shown
on the monitor. Furthermore, this comment indicates an insuffi-
cient awareness of the possibility to adjust contrast settings on the
aView monitor. Qualitative comments, such as ‘ability to use
screen for recording/teaching/explanation is very useful’ indicate
the additional advantages of having a monitor compared to the
eyepiece; the quantitative data do not reflect this advantage.
Fig. 4. Categorisation of (a) negative, (b) neutral and (c) positive comments relating
to the single-use rhinolaryngoscope.
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User acceptability: advancing and navigation
In total, 95 per cent of investigators scored navigation with the
single-use rhinolaryngoscope as ‘acceptable’ or ‘better’ than
that with the reusable rhinolaryngoscope. This was the only
evaluated variable that had a significant effect on investigators’
perceptions of whether the single-use rhinolaryngoscope can
replace the reusable rhinolaryngoscope. Comparative data fur-
ther demonstrated that 59 per cent of investigators thought the
single-use rhinolaryngoscope was ‘acceptable’ or ‘better’ than
the reusable scope. Despite the preference towards the single-
use rhinolaryngoscope, the qualitative data included negative
comments, including ‘felt very uncomfortable as upside-down
to normal position’, and ‘less flexible: navigation in a difficult
nose may be difficult’.
All investigators, except for one core surgical trainee, had
gained significant experience using the reusable rhinolaryngo-
scope throughout their careers. Navigation is likely to be
associated with reversal learning and a renewal effect.21
Therefore, a more valid and comparative dataset for evaluating
advancing and navigation could be acquired if reusable rhinolar-
yngoscopes and single-use rhinolaryngoscopes were provided to
novices with similar levels of experience and over a longer period
of time.
User acceptability: patient selection
A common theme highlighted in the qualitative data was the
importance of patient selection. Comments included ‘not
replaceable for certain cases – should have the reusable
scope available in case’, ‘had to swap to paediatrics scope as
patient gagged’, and ‘difficult patients need reusable scope’.
Hence, if a patient was deemed to have complex anatomy, or
had a smaller airway, then the single-use rhinolaryngoscope
would be less preferential than the reusable rhinolaryngoscope
in light of the image quality and perceived navigation
Fig. 5. (a) The base-case for eyepiece, video and single-use rhinolaryngoscopes, in the out-patient clinic (OPC) and acute surgical assessment unit (aSAU). The total
cost was segmented into capital, repair and reprocessing costs. (b) One-way sensitivity analysis for the cost of procedures, dependent on the volume of procedures
each year. (c & d) Two-way sensitivity analysis showed dominant dependence on reprocessing and capital costs in the (c) out-patient clinic and (d) acute surgical
assessment unit.
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problems. However, our study did not quantify the effect of
time on the perception of navigation. The perception of navi-
gation is likely to improve as investigators gain more practice
with the single-use rhinolaryngoscope.
Environmental impact and cost
The incremental cost for each procedure is dependent on the
clinical setting and the volume of procedures. We found that
the new single-use rhinolaryngoscope was an effective and
cost-minimising alternative in the acute surgical assessment
unit, where the volume of procedures per rhinolaryngoscope
was lower than in the out-patient clinic. The volume of proce-
dures was previously shown to have a direct impact on the pro-
cedural cost for reusable endoscopes in a large teaching
hospital in the UK.22 In accordance with McCahon and
Whynes (2015), the high volume of procedures in the out-
patient clinic pushed the capital and repair costs for reusable
scopes below the cost of single-use rhinolaryngoscopes.22
• The single-use rhinolaryngoscope eliminates the serious potential risk of
prion transmission in ENT endoscopy
• It provides comparable functionality to the reusable rhinolaryngoscope in
terms of image quality, ergonomics, and advancing and navigation
• The single-use rhinolaryngoscope is a cost-minimising alternative in the
acute surgical assessment unit, where volume of procedures per
rhinolaryngoscope is lower than in an out-patient setting
Participants were also aware of the potential environmen-
tal impact of single-use rhinolaryngoscopes; comments
included ‘have to empty/change bins and delay clinic as full
up of used scopes – additional hospital costs re: change
waste’ and ‘just used for rhinology/post-nasal space exam.
Felt extravagant to use for that as not great view’. However,
a previous study carried out a specific environmental com-
parison of single-use bronchoscopes in comparison with
reusable bronchoscopes, and demonstrated that the single-
use system had a similar environmental impact as reproces-
sing reusable bronchoscopes.14
Study limitations
There were a number of limitations to our study that must be
considered. First, despite our overall positive results, it is
impossible to state conclusively that the single-use rhinolaryn-
goscope is better than the reusable rhinolaryngoscope without
a comparative dataset. Consequently, there is a clear need for
further research in this area. Second, the exact anatomical
structures visualised during the procedures carried out by
our investigators were not documented. Third, this study did
not take the investigators’ learning curves into consideration;
consequently the initial training session was not mandatory
for all investigators. Fourth, the overall low level of compliance
(29.5 per cent, 59 out of 200) demonstrated that the majority
of procedures were not reported. This reduces internal and
external validity, but also implies limitations in the range of
procedures performed with the single-use rhinolaryngoscope.
Fifth, a range of doctors participated in this study, with the
vast majority being at the consultant level. Consequently, feed-
back was provided by doctors with a sufficient level of conso-
lidated experience to enable appropriate comparison with the
reusable rhinolaryngoscope. It is possible that reversal learning
and the renewal effect, factors known to be involved in the
adoption of new technology,21 might lead to a certain level
of reluctance in doctors to adopt the single-use rhinolaryngo-
scope. Sixth, because of limited access to cost data, some of the
costs used in our calculations were based on assumptions from
cost analyses carried out in other UK hospitals. Therefore, the
actual procedural costs within St George’s University Hospital
may differ from our base-case.
Finally, we must highlight the fact that the context (setting
and indication) within which the data were obtained was not
recorded in every feedback form. This is important as the
desired functionality of the rhinolaryngoscope may change.
For example, in an acute admission, it is very important to
rapidly assess the overall state of the airway; in the out-
patient department, priority is given to the assessment of
finer details.
Future recommendations
Future research should involve a comparative, prospective study,
carried out in different clinical settings over a longer period of
time, which includes the eyepiece, video and single-use rhino-
laryngoscopes. Such work will be important in comparing the
ability of these systems to clinically assess patients, and evaluate
their overall impact at an organisational level. Research also
needs to assess the impact of the portable image monitor on:
the wider otolaryngology team, clinician learning, documenta-
tion, medical education and the patients’ perspective.
Conclusion
The Ambu aScope 4 RhinoLaryngo Slim single-use rhinolar-
yngoscope provides a user experience that is clinically compar-
able to the reusable rhinolaryngoscope, at least with regard to
all of the variables evaluated in this study. The perception of
navigation had a significant influence on investigators’ opi-
nions of whether this system can replace reusable rhinolaryn-
goscopes. In the acute surgical assessment unit, the Ambu
aScope 4 RhinoLaryngo Slim single-use rhinolaryngoscope
provides a cost-equivalent alternative to the reusable eyepiece
rhinolaryngoscope, and a cost-minimising alternative to
reusable video rhinolaryngoscopes.
Supplementary material. The supplementary material for this article can
be found at https://doi.org/10.1017/S0022215120001656.
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